Chen et al. found that the oncogene ECT2 (epithelial cell transforming) expressed by CTCs in peripheral blood was more sensitive than serum CEA levels, particularly in advanced-stage CRC patients, and its expression on CTC surfaces was identified as a potential prognostic marker for CRC (Wang et al., 2019). This evidence concerns the gene ECT2 and colorectal carcinoma.